trial · primary record
AMX-883
Acute Myeloid Leukaemia
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 54 |
| Primary completion | 2029-04-30 |
| Primary endpoint | Number of participants with adverse events (AEs), treatment-emergent adverse events (TEAEs), adverse events of special interests (AESIs) and serious adverse events (SAEs) |
| Registry ID | NCT07723703 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:20.483Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07723703
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.